Covid 19 emerging as etiology for novel phenotype of Asthma

<bold>Background:</bold> In India, concerns are rising about "long-COVID" symptoms after surviving COVID-19. Studies suggest a significant portion, especially those with severe infections, develop cough, wheezing, and shortness of breath similar to asthma. We are now entering a post-COVID era in which many postCOVID-19 patients continue to suffer from respiratory symptoms like coughing, dyspnea, or wheezing even after the viral infection has subsided. <bold>Objective:</bold> The Study aims to evaluate the clinical presentation ,lab values along with lung function In Covid 19 affected patients. <bold>Methods:</bold> 140 individuals with a record of COVID-19 pneumonia and asthma like symptoms were enrolled and evaluated in 12 month on basis of clinical presentation, Serum IgE, absolute eosinophil count. PFT parameters like FEV1, FEV25-75 were assessed. <bold>Results:</bold> Patient who had mild Covid 19 pneumonia having oxygen saturation above 95% and not requiring oxygen support comprises of 76(57%), those who needed hospital admission due to oxygen saturation below 90% comprises of 20 (14%) and with moderate covid pneumonia with spo2 between 90-95% include 44(31.4%). Predominant symptoms were cough in 133(95%), followed by wheezing in 120 (85.6%) but breathlessness in 60(42%) only. Spirometry is normal in 86(61.4%), whereas mild obstruction in 20(14.2%) and 34(24.2%) patients had only small airway obstruction. In lab parameters, AEC is below 200 in 113(80.7%) and above 200 only in 27(19.2%) where as Serum IgE(Total) is above 500IU in 18(12.8%), 200-500 in 82(58.5%) and normal range in 40(28.5%). <bold>Conclusion:</bold> Our study suggest that recent COVID-19 infection is leading to new varient of asthma with preserved lung function and peculiar lab values than Asthma which we are aware of.